The development of Birmingham Health Innovation Campus (formerly known as Birmingham Life Sciences Park) has taken a major step forward today, with the announcement of a new long-term partnership between the University of Birmingham and the UK’s leading property provider for the science and technology sector, Bruntwood SciTech, a 50:50 joint venture between Bruntwood and Legal & General.
8 Oct 2020
A £210m, 10-year masterplan will be developed for the Campus, which will provide up to 657,000 sq ft of state-of-the-art lab, office and incubation space acting as a catalyst for the growth of the Midlands’ life sciences sector. It is set to create upto 10,000 new jobs and contribute £400m GVA to the regional economy by 2030.
The Campus was recently awarded Life Science Opportunity Zone status by the Department for Business, Energy and Industrial Strategy (BEIS) and has been awarded development funding from Birmingham City Council and the Greater Birmingham and Solihull Local Enterprise Partnership. It sits at the heart of an important cluster of health excellence led by Birmingham Health Partners (BHP), a strategic alliance between the University of Birmingham, University Hospitals Birmingham NHS Foundation Trust and Birmingham Women’s and Children’s NHS Foundation Trust.
The first phase of the development includes a new 130,000 sq ft purpose-built, six-storey building which will be home to BHP’s Precision Health Technologies Accelerator (PHTA), providing incubation space, cleanrooms, prototyping and makerspace as well as the Birmingham Precision Medicine Centre and Healthcare Technologies Innovation Hub. It will also be a hub for businesses working in medtech, biopharma, precision medicine, healthcare AI, and genomics, with the opportunity to access a fully connected clinical trials translation ecosystem and collaborate with academia and clinicians for commercialising and rapid translation into the healthcare system. This will in turn accelerate the development and deployment of new drugs, diagnostics and healthcare technologies to patients and provide a pathway for innovation challenges in the NHS to be met at scale.
Work will begin on an extensive public consultation in the coming months, with the first phase currently set to complete in 2023.
Dr David Hardman, Managing Director, Bruntwood SciTech- Birmingham: "This is a huge opportunity for the UK’s life science sector. By creating an environment that will not only help businesses to form, scale, collaborate and grow, we will establish a new thriving life sciences hub, which will create much needed capacity for the West Midlands and help to attract further international investment to the region and beyond.
Working alongside Birmingham Health Partners, Birmingham Health Innovation Campus will help to align academic, NHS and industry capabilities. It will also provide additional much-needed world class facilities for pioneering healthcare businesses and will bolster the UK’s position as a life sciences leader on the global stage."
Professor Tim Jones, University of Birmingham Provost and Vice-Principal: "With access to Birmingham’s world-class genomics laboratories, health data programmes, healthcare technology development teams, clinical trials leadership and academic expertise, Birmingham Health Innovation Campus will become the ideal place for innovative health and life sciences businesses to thrive.
This ambitious new development will leverage the expertise of the existing Birmingham Health Partners ecosystem to drive innovation and economic growth – all centred on a shared mission to transform the health of all citizens, in Birmingham and beyond, by accelerating the development and adoption of healthcare innovations."
Eleanor Jukes, Senior Investment Manager – Future Cities at Legal & General Capital: "The Birmingham Health Innovation Campus, once completed, will provide world-leading office and lab facilities which will not only boost economic growth and job opportunities in the region, but also aid the development of potentially life-saving treatments and technologies. Over the next ten years this landmark scheme will unlock over 10,000 new jobs and contribute around £400m to the local region, acting as a major catalyst for economic recovery in the wake of Covid-19."
Andy Street, Mayor of the West Midlands: "Life sciences is an incredibly exciting and important sector that we have been quietly growing in the West Midlands over the last few years. Now with today’s announcement we are cementing our ambition to be one of the global leaders in this sector.
The timing of this announcement, given the clear current economic challenges, is also critical. By acting as a catalyst for investment, the campus will help to create a significant number of high-quality, well-paid, local jobs for local people.
Today’s announcement is momentous for the West Midlands. I applaud Birmingham Health Partners and welcome Bruntwood SciTech, and I am pleased to have played my part in making it happen."
Established in 1836, Legal & General is one of the UK's leading financial services groups and a major global investor, with over £1.2 trillion in total assets under management* of which 39% is international. We have a unique and highly synergistic business model, which continues to drive strong returns. Legal & General provides powerful asset origination and management capabilities directly to clients, which also underpin our leading retirement and protection solutions. We are a leading international player in Pension Risk Transfer, in UK and US life insurance, and in UK workplace pensions and retirement income. Our purpose is to improve the lives of our customers and create value for our shareholders. Through inclusive capitalism, we are investing in long-term assets, such as real estate and infrastructure, that can help build a better society for the future.
*as at HY 2023
Legal & General Capital (LGC) is Legal & General Group’s alternative asset platform, creating assets for Legal & General Retirement and third-party clients in order to achieve improved risk-adjusted returns for our shareholders. LGC has built its capabilities in a range of alternative sectors, including in residential property; specialist commercial real estate; clean energy; alternative credit; and venture capital, which are all supported by long-term structural growth drivers, meet a financing gap and respond to a scarcity of supply that is underpinned by enduring societal needs.
Its purpose is to invest society’s capital for society’s benefit. Investing in the real economy and supporting the Group’s focus on climate and inclusive capitalism, LGC’s investments create jobs, change lives and contribute towards a net zero carbon future.
Legal & General has invested over £29bn in levelling-up regional economies, including through major UK-wide regeneration schemes and has recently made a commitment to enable all its new homes to operate at net zero carbon emissions from 2030.
*at 31 Jun 2021